0001736945-18-000006.txt : 20180530 0001736945-18-000006.hdr.sgml : 20180530 20180530145303 ACCESSION NUMBER: 0001736945-18-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180530 DATE AS OF CHANGE: 20180530 EFFECTIVENESS DATE: 20180530 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-313514 FILM NUMBER: 18867751 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 D 1 primary_doc.xml X0708 D LIVE 0001610618 Cidara Therapeutics, Inc. 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA CALIFORNIA 92121 858-752-6170 DELAWARE K2 THERAPEUTICS, INC. Corporation true Jeffrey Stein c/o Cidara Therapeutics, Inc. 6310 Nancy Ridge Dr San Diego CA CALIFORNIA 92121 Executive Officer Director Daniel D Burgess c/o Cidara Therapeutics, Inc. 6310 Nancy Ridge Dr San Diego CA CALIFORNIA 92121 Director Scott M Rocklage c/o Cidara Therapeutics, Inc. 6310 Nancy Ridge Dr San Diego CA CALIFORNIA 92121 Director Theodore R Schroeder c/o Cidara Therapeutics, Inc. 6310 Nancy Ridge Dr San Diego CA CALIFORNIA 92121 Director Robert J Perez c/o Cidara Therapeutics, Inc. 6310 Nancy Ridge Dr San Diego CA CALIFORNIA 92121 Director Timothy R Franson c/o Cidara Therapeutics, Inc. 6310 Nancy Ridge Dr San Diego CA CALIFORNIA 92121 Director Matthew Onaitis c/o CidaraTherapeutics, Inc. 6310 Nancy Ridge Dr San Diego CA CALIFORNIA 92121 Executive Officer Taylor Sandison c/o CidaraTherapeutics, Inc. 6310 Nancy Ridge Dr San Diego CA CALIFORNIA 92121 Executive Officer Chrysa Mineo c/o CidaraTherapeutics, Inc. 6310 Nancy Ridge Dr San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2018-05-23 true true true false 0 1874999 1562499 312500 Represents warrants to purchase shares of Common Stock; such warrants have not yet been exercised. false 16 1950000 0 Sales Commission amount also covered the $120.0 million concurrent registered direct offering. The Issuer has also agreed to reimburse the placement agents for certain of their expenses related to the offering in an amount up to $40,000. 0 false Cidara Therapeutics, Inc. /s/ Matthew Onaitis Matthew Onaitis Chief Financial Officer 2018-05-29